The metabolic disorder known as Gilbert's Syndrome – symptoms, causative factors, diagnostic methods, and pregnancy

Gilbert Syndrome is a hereditary metabolic disorder affecting the processing of bilirubin, a red-orange pigment. It affects 5-7% of the population, occurring more frequently in males than females. Despite being a well-documented condition, this genetic anomaly is rarely discussed in public discourse. While the syndrome is thoroughly understood in medical literature, it remains largely unfamiliar and enigmatic to the general public. Are there significant complications associated with it, and what treatment options are available?

In the majority of cases, this condition does not produce any noticeable symptoms. Diagnosis is typically made incidentally during routine medical screenings. It does not interfere with daily life, as evidenced by research indicating that a subset of individuals with the genetic mutation remains unaware of any metabolic disturbances. The sole noticeable indicator may be the intermittent occurrence of jaundice affecting the skin, mucous membranes, and sclera. This phenomenon most commonly manifests in adolescent boys but can also be triggered by excessive stress, alcohol intake, strenuous physical activity, or in women during the premenstrual phase.

To grasp the pathogenesis of this condition, it is essential to explain the role of bilirubin and the liver's function in eliminating it from the body. Bilirubin is generated through the breakdown of heme, a component of hemoglobin, the red blood pigment (present in erythrocytes). Upon release from erythrocytes during their degradation, heme is converted into bilirubin. Under normal conditions, bilirubin should be transported to the liver, where it conjugates with glucuronic acid and is excreted via bile. In individuals with Gilbert Syndrome, a mutation occurs in the gene encoding UDP-glucuronyltransferase, an enzyme critical for the proper progression of this process. What are the implications of this mutation? Bilirubin accumulates in the bloodstream at excessive levels, resulting in jaundice. Each occurrence of such symptoms necessitates thorough diagnostic evaluation to rule out other, potentially more hazardous causes. Gilbert Syndrome does not pose a life-threatening risk.

Jaundice of the skin and mucous membranes necessitates an immediate assessment of liver function. To diagnose Gilbert's Syndrome, several tests are required, including the evaluation of liver enzymes (ALT, AST, ALP, GGT), albumin, and other liver parameters. If the results are normal and hemolytic anemia is ruled out, a genetic test for mutations in the UGT1A1 gene should be considered. Unfortunately, this test is not covered by national health insurance. A common diagnostic approach involves administering 90-150 mg of fenobarbital over several days. If Gilbert's Syndrome is confirmed, bilirubin levels should decrease. While the diagnosis typically does not significantly impact quality of life, patients should avoid factors that exacerbate hyperbilirubinemia, such as stress, excessive physical exertion, or alcohol consumption.

Gilbert Syndrome, stemming from a genetic variation, does not interfere with daily life. Pregnant women with this condition should not be concerned, as intermittent bilirubin elevations pose no risk. Prioritizing stress management and proper nutrition is essential. It is important to note that this condition does not require treatment, but proactive self-care and a healthy lifestyle are key.